{{Rsnum
|rsid=10183087
|Gene=ICOS
|Chromosome=2
|position=203959601
|Orientation=plus
|GMAF=0.2622
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ICOS
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 54.9 | 38.9 | 6.2
| HCB | 75.0 | 23.5 | 1.5
| JPT | 68.1 | 28.3 | 3.5
| YRI | 34.9 | 47.3 | 17.8
| ASW | 42.1 | 47.4 | 10.5
| CHB | 75.0 | 23.5 | 1.5
| CHD | 66.1 | 29.4 | 4.6
| GIH | 41.6 | 42.6 | 15.8
| LWK | 26.4 | 45.5 | 28.2
| MEX | 60.3 | 36.2 | 3.4
| MKK | 26.9 | 55.1 | 17.9
| TSI | 61.8 | 33.3 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21526489
|Title=ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population
}}

{{PMID Auto
|PMID=21917182
|Title=ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study
|OA=1
}}

{{PMID Auto
|PMID=19202444
|Title=Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation.
}}

{{PMID Auto
|PMID=19672595
|Title=Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
|OA=1
}}

{{PMID Auto
|PMID=19747393
|Title=Improving power in genetic-association studies via wavelet transformation.
|OA=1
}}

{{PMID Auto
|PMID=22977635
|Title=Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population
|OA=1
}}

{{PMID Auto
|PMID=24083358
|Title=Effect of Soluble Inducible Costimulator Level and Its Polymorphisms on Age-Related Macular Degeneration
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}